Earnings Preview: What To Expect From Biogen
With a market cap of $17.4 billion, Biogen Inc. (BIIB) is a global biotechnology leader focused on discovering, developing, and delivering innovative therapies for serious neurological and neurodegenerative diseases. Its portfolio…
